Therefore, the aim of our study was to investigate PD-L1 expression in tumour cells and immune cells separately using immunohistochemistry and compare the PD-L1 combined positive score (CPS) between the primary GC and matched regional lymph node metastasis and/or distant metastasis using CPS cut-off 1 and 5. This evidence concerns the gene CD274 and neoplasm.